Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know
3 Reasons to Sell DGX and 1 Stock to Buy Instead
Are Medical Stocks Lagging Quest Diagnostics (DGX) This Year?
Quest Diagnostics Stock: Analyst Estimates & Ratings
Why Is Quest Diagnostics (DGX) Down 5% Since Last Earnings Report?
Reasons to Add Align Technology Stock to Your Portfolio Now
Quest Diagnostics Declares Quarterly Cash Dividend
Is This the Right Time to Hold DGX Stock in Your Portfolio?
Quest Diagnostics (NYSE:DGX): A Solid Dividend Play Backed by Strong Profitability and Financial Health
Quest Diagnostics: Updating Levels After Q1 Earnings
Quest Diagnostics Debt Raise And ctDNA Alliance Spark Valuation Questions
5 Must-Read Analyst Questions From Quest’s Q1 Earnings Call
Quest Diagnostics Prices $500 Million of Senior Notes
Orkes Raises $60M as Developers Increasingly Use Its Platform to Deploy AI Confidently in Production
Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely
UBS Maintains Neutral on Quest Diagnostics, Raises Price Target to $220
DGX Q1 Deep Dive: Organic Growth, Consumer Testing Momentum, and Advanced Diagnostics Drive Outlook
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings
Baird Maintains Neutral on Quest Diagnostics, Raises Price Target to $229
Barclays Maintains Overweight on Quest Diagnostics, Raises Price Target to $230
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.